Phase I/II study evaluating escalating subcutaneous doses of recombinant human albumin-interferon-alpha fusion protein in chronic hepatitis C patients who have failed previous interferon-alpha-based therapy - Balan,V.; Nelson,D.R.; Sulkowski,M.S. (Antivir Ther, 2006)